{"id":"https://openalex.org/W4313360294","doi":"https://doi.org/10.4049/jimmunol.196.supp.75.5","title":"The clinical-stage TLR5 agonist, Entolimod, mediates antimetastatic activity by stimulating a CXCR3-dependent NK-DC-CD8+ T cell axis","display_name":"The clinical-stage TLR5 agonist, Entolimod, mediates antimetastatic activity by stimulating a CXCR3-dependent NK-DC-CD8+ T cell axis","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W4313360294","doi":"https://doi.org/10.4049/jimmunol.196.supp.75.5"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.196.supp.75.5","doi":"https://doi.org/10.4049/jimmunol.196.supp.75.5","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.196.supp.75.5","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038923700","display_name":"Craig M. Brackett","orcid":"https://orcid.org/0000-0001-9897-5276","observed_orcids":["https://orcid.org/0000-0001-9897-5276"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig M Brackett","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053311556","display_name":"Bojidar Kojouharov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bojidar M Kojouharov","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082241355","display_name":"Sandra Oppel Gollnick","orcid":"https://orcid.org/0000-0001-6493-9306","observed_orcids":["https://orcid.org/0000-0001-6493-9306"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra O Gollnick","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087204160","display_name":"Lyudmila G. Burdelya","orcid":"https://orcid.org/0000-0001-8632-9154","observed_orcids":["https://orcid.org/0000-0001-8632-9154"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lyudmila G Burdelya","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058401562","display_name":"Scott I. Abrams","orcid":"https://orcid.org/0000-0002-8742-4708","observed_orcids":["https://orcid.org/0000-0002-8742-4708"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott I Abrams","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069808553","display_name":"Andrei V. Gudkov","orcid":"https://orcid.org/0000-0003-2548-0154","observed_orcids":["https://orcid.org/0000-0003-2548-0154"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrei V Gudkov","raw_affiliation_strings":["Roswell Park Cancer Inst","1Roswell Park Cancer Inst"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"1Roswell Park Cancer Inst","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"196","issue":"1_Supplement","first_page":"75.5","last_page":"75.5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tlr5-agonist","display_name":"TLR5 agonist","score":0.9639999866485596},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.6430000066757202},{"id":"https://openalex.org/keywords/cxcr3","display_name":"CXCR3","score":0.7950000166893005},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8450000286102295},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.7749999761581421},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7940000295639038},{"id":"https://openalex.org/keywords/immunoadjuvant","display_name":"immunoadjuvant","score":0.7519999742507935},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7139999866485596},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.7609999775886536},{"id":"https://openalex.org/keywords/ap-1","display_name":"AP-1","score":0.7720000147819519},{"id":"https://openalex.org/keywords/acute-radiation-syndrome","display_name":"radiation sickness","score":0.609000027179718},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.6740000247955322},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.6620000004768372},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8259999752044678},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C2777338127","wikidata":"https://www.wikidata.org/wiki/Q14914085","display_name":"TLR5","level":5,"score":0.6304980516433716},{"id":"https://openalex.org/C25532541","wikidata":"https://www.wikidata.org/wiki/Q655541","display_name":"CXCR3","level":5,"score":0.5714450478553772},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5657505393028259},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5200850367546082},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.516326367855072},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4921812117099762},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4894930124282837},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4754100441932678},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4738341271877289},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4664202630519867},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44916871190071106},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3392942547798157},{"id":"https://openalex.org/C2776709828","wikidata":"https://www.wikidata.org/wiki/Q408004","display_name":"Toll-like receptor","level":4,"score":0.2599338889122009},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.24215102195739746},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.23148339986801147}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.196.supp.75.5","doi":"https://doi.org/10.4049/jimmunol.196.supp.75.5","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.196.supp.75.5","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2802489086","https://openalex.org/W2900391882","https://openalex.org/W2272817250","https://openalex.org/W2395538682","https://openalex.org/W1574828085","https://openalex.org/W2760907457","https://openalex.org/W1966830804","https://openalex.org/W4313414163","https://openalex.org/W1186717816","https://openalex.org/W4313366292"],"abstract_inverted_index":{"Abstract":[0],"Activation":[1],"of":[2,19,28,30,37,85,95,99,112,164,190,195,200,227],"an":[3,9,151],"anticancer":[4],"innate":[5,22,118],"immune":[6,23],"response":[7],"is":[8,14],"attractive":[10],"immunotherapeutic":[11,179],"opportunity":[12,212],"that":[13,108,116,158],"challenged":[15],"by":[16,40,133],"insufficient":[17],"safety":[18,71],"systemically":[20,146],"administered":[21,147],"modulators.":[24],"Unusual":[25],"tissue":[26],"specificity":[27],"expression":[29],"TLR5":[31,43,148],"determines":[32],"a":[33,47,110,173,187,196],"uniquely":[34],"safe":[35],"profile":[36],"cytokines":[38],"induced":[39],"the":[41,123,211],"sole":[42],"agonist":[44],"flagellin.":[45],"Entolimod,":[46],"pharmacologically":[48],"optimized":[49],"flagellin":[50],"derivative,":[51],"was":[52],"initially":[53],"developed":[54],"to":[55,122,213],"treat":[56],"and":[57,67,70,90,102,119,136,176],"prevent":[58],"acute":[59],"radiation":[60],"syndrome":[61],"with":[62,204],"demonstrated":[63,79,217],"efficacy":[64,216],"in":[65,72,82,106,202,218],"rodents":[66],"non-human":[68],"primates":[69],"human":[73,228],"healthy":[74],"volunteers.":[75],"In":[76],"addition,":[77],"Entolimod":[78,168,201],"antitumor":[80,137,156],"effects":[81],"mouse":[83],"models":[84,221],"uveal":[86],"melanoma,":[87],"lymphoma,":[88],"breast,":[89],"colorectal":[91],"carcinoma.":[92],"Entolimod\u2019s":[93],"mechanism":[94],"action":[96],"involves":[97],"activation":[98,135],"NF-\u03baB-,":[100],"AP-1-,":[101],"STAT-3-driven":[103],"immunomodulatory":[104],"pathways":[105],"hepatocytes":[107],"initiates":[109],"cascade":[111],"cell-cell":[113],"signaling":[114],"events":[115],"mobilize":[117],"adaptive":[120],"immunity":[121],"liver.":[124],"This":[125],"includes":[126],"CXCR3-dependent":[127],"blood-borne":[128],"NK":[129],"cell":[130,140],"homing":[131],"followed":[132],"DC":[134],"CD8+":[138],"T":[139],"memory":[141],"formation.":[142],"These":[143],"results":[144],"define":[145],"agonists":[149],"as":[150,172],"organ-specific":[152],"immunoadjuvant":[153],"enabling":[154],"efficient":[155],"vaccination":[157],"does":[159],"not":[160],"depend":[161],"on":[162],"identification":[163],"tumor-specific":[165],"antigens.":[166],"Therefore,":[167],"has":[169,209],"strong":[170],"promise":[171],"safe,":[174],"effective":[175],"broadly":[177],"applicable":[178],"agent":[180],"against":[181],"liver":[182],"metastases,":[183],"which":[184],"are":[185],"currently":[186],"major":[188],"cause":[189],"cancer-associated":[191],"mortality.":[192],"Recent":[193],"completion":[194],"phase":[197],"I":[198],"trial":[199],"patients":[203],"advanced":[205],"metastatic":[206],"solid":[207],"tumors":[208],"opened":[210],"test":[214],"whether":[215],"animal":[219],"cancer":[220],"could":[222],"be":[223],"translated":[224],"into":[225],"immunotherapy":[226],"tumors.":[229]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-01-06T00:00:00"}